![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
Objectives: Treatment decisions for children with attention-deficit/hyperactivity disorder (ADHD) should include parents’ preferences, since parents’ acceptance and support are crucial for ensuring treatment adherence and, as a consequence, good clinical outcomes. Discrete choice experiments (DCEs, also known as conjoint experiences) are an important technique for identification and assessment of preferences for different treatment characteristics. In this study, a DCE was performed to analyze and to discuss parents’ preferences regarding ADHD treatment for their school-aged children. Methods: This article presents a mixed-method approach; qualitative and quantitative methods were used to ascertain the attributes that might influence a parent’s choices for the optimal management of their child with ADHD. Parents of patients with ADHD in Germany completed a self-administered survey. Relevant characteristics of an ideal ADHD treatment were collected by reviewing the literature and by conducting a qualitative study with focus groups. The study involved a subgroup of parents of school-age children aged 6–14 years (n = 121). Attitudes were measured and analyzed using a classic rating scale (5-point Likert format). Preferences were elicited using a DCE; scenarios were analyzed using a random-effects logit model. Results: A total of 121 questionnaires were completed by caregivers (101 mothers, 16 fathers and four others) on behalf of their school-age children (6–14 years, 87% male). Six main attributes were investigated regarding their impact on parent preferences for ADHD treatment. While all were statistically significant in the DCE, improvements in the child’s social situation (coefficient: 2.812; odds ratio: 16.64) and emotional state (coefficient: 1.610; odds ratio: 5.00) were rated as the most important by parents. Conclusion: The study provides a valuable insight into parents’ preferences regarding treatment for their child with ADHD. If physicians can incorporate this information into their treatment plans for children with ADHD, greater concordance regarding treatment goals, adherence with therapy and, ultimately, clinical outcomes may be achieved.
Acknowledgements
Our special thanks go to the patient advocacy group ‘ADHS Deutschland e.V.’ for their support in conducting this study. Dr Katrin Wolf, Dr Peter Weber and Steve Clissold PhD supported the editing of this article. Janssen-Cilag (Neuss, Germany) supported the underlying studies and this analysis with both financial contributions and by sharing medical knowledge and comments.
Authors’ contributions
Axel Mühlbacher and Matthias Nübling developed the design of the discrete choice experiment, collected the data and performed the statistical analysis. Jörg M Fegert developed the study design of the subgroup analysis and Jörg M Fegert, Lara Slawik and Detlef Wermelskirchen performed the interpretation of data.
Financial & competing interests disclosure
Over the past 5 years, Jörg M Fegert has received unrestricted research grants from Eli Lilly Foundation, from Janssen-Cilag and from Celltech/USB. He received travel grants from or served as a consultant to Aventis, Bayer, Bristol-Myers Squibb, Johnson & Johnson, Celltech/USB, Lilly, Medice, Novartis, Pfizer, Ratiopharm, Sanofi-Synthelabo, Servier, VFA and Generikaverband and was involved in clinical trials with Janssen-Cilag, Medice, Lilly, Astra Zeneca. Lara Slawik and Detlef Wermelskirchen are employed by Janssen-Cilag, Germany. Over the past 5 years, Matthias Nübling has received research funding from Merck Serono and Janssen-Cilag. Over the past 5 years, Axel Mühlbacher has received research funding from Lilly Deutschland GmbH, Pfizer, Janssen-Cilag, Berlin Chemie. Janssen-Cilag (Neuss, Germany) supported the underlying studies and this analysis with financial contributions. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Writing assistance was provided by Content Ed Net. This writing assistance was funded by Janssen-Cilag (Neuss, Germany).
